THE NICKLES GROUP, LLC for BAXALTA INC.
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Issues related to corporate tax reform and the taxation of U.S. multinational corporations. S. 149, the Medical Device Access and Innovation Protection Act and H.R. 160, the Protect Medical Innovation Act, and issues related to repeal of the medical device tax. H.R. 880, the American Research & Competitiveness Act, S. 537. COMPETE Act, and issues related to the R&D tax credit. H.R. 2510 and S. 1660, to make permanent bonus depreciation. Issues related to bonus depreciation. H.R. 1430, to make permanent the CFC look-through rule. S. 1946, the Tax Relief Extension Act of 2015, as it relates to the R&D credit, bonus depreciation, and the CFC look-through rule. Issues related to corporate mergers.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RACHEL JONES HENSLER | — |
| EMILY PORTER | — |
| MARY BETH SAVARY TAYLOR | — |
Medicare/Medicaid MMM
H.R. 2570, Strengthening Medicare Advantage through Innovation and Transparency for Seniors; S. 275 / H.R. 605, the Medicare Home Infusion Site of Care Act of 2015 and issues related to reimbursement for infused drugs administered through DME.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EMILY PORTER | — |
| MARY BETH SAVARY TAYLOR | — |
Budget/Appropriations BUD
The FY'16 budget reconciliation bill as it relates to the repeal of the medical device tax.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RACHEL JONES HENSLER | — |
Health Issues HCR
H.R. 6, The 21st Century Cures Act and the Innovations Initiative. Issues concerning care for chronic disease patients.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EMILY PORTER | — |
| MARY BETH SAVARY TAYLOR | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.